By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
NZ dollar at 18-month high vs euro on ECB extension, seen weaker as yield premium shrinks
MARKET CLOSE: NZ shares fall; Spark, Scales drop while Orion, Tower bounce
Cooks doubles 1H loss, seeks equity to fund Chinese growth
Anadarko drops offshore oil prospect, still 'committed to NZ'
BurgerFuel narrows 1H loss, plans to buy more franchised stores, expand into US
Stop calling KiwiSaver suspension a 'holiday', says Retirement Commissioner
NZ credit, debit card spending falls in November amid earthquake disruption
Ex-Auckland Transport staffer and supplier found guilty over $1M-plus bribes
NZ wool prices fall at weekly auction as supply exceeds expectations
Mercer sells 130.8M shares to fund acquisition, one-third sold to managers